Development of pathogenicity predictors specific for variants that do not comply with clinical guidelines for the use of computational evidence.

We see that, apart from an overall trend towards lower success rates, the results are comparable to those obtained for VS228: specific predictors tend to outperform reference predictors and, as the performance of the latter improves, the difference between approaches decreases.

also in 4,871 other papers